Akaal Pharma is a clinical-stage drug discovery and development company focused on developing small molecule drugs for the treatment of autoimmune, inflammatory, and pain indications. It has a pipeline of topical and oral drugs for the treatment of dermatological diseases (atopic dermatitis, psoriasis), pain (arthritis), and autoimmune diseases including multiple sclerosis.